Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:May 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:May 15, 2023Recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:December 15, 2022Withdrawn
Condition(s):NeoplasmsLast Updated:January 23, 2014Completed
Condition(s):Relapsed or Refractory Acute Myeloid LeukemiaLast Updated:August 30, 2022Recruiting
Condition(s):Advanced Solid TumorsLast Updated:February 9, 2024Completed
Condition(s):Breast CancerLast Updated:December 5, 2023Not yet recruiting
Condition(s):Advanced Malignant TumorLast Updated:September 10, 2022Suspended
Condition(s):Breast CancerLast Updated:February 23, 2024Terminated
Condition(s):Peripheral T Cell LymphomaLast Updated:December 16, 2020Not yet recruiting
Condition(s):Advanced Gastric CarcinomaLast Updated:March 7, 2024Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.